Article
Interleukin-38 promoter variants and risk of COVID-19 among Iraqis.
Immunobiology - 1 Nov 2022
Al-Karaawi Ibtihal A, Al-Bassam Wasan W, Ismaeel Haneen M, Ad'hiah Ali H
Abstract excerpt
Coronavirus disease-19 (COVID-19) has recently emerged as a respiratory infection with a significant impact on health and society. The pathogenesis is primarily attributed to a dysregulation of cytokines, especially those with pro-inflammatory and anti-inflammatory effects. Interleukin-38 (IL-38) is a recently identified anti-inflammatory cytokine with a proposed involvement in mediating COVID-19 pathogenesis,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
